SCHEMBL1796208

SCHEMBL1796208

N#Cc1ccc(-c2cc(-c3ccccc3)no2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.71
RAB9A P51151 6/20 0.71
CASP3 P42574 1/20 0.64
SENP8 Q96LD8 1/20 0.64
SENP7 Q9BQF6 1/20 0.64
SENP6 Q9GZR1 1/20 0.64
PTGS2 P35354 2/20 0.56
CYP3A4 P08684 2/20 0.56
CXCR1 P25024 5/20 0.55
GABRA1 P14867 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51
GABRA3 P34903 1/20 0.51
MYC P01106 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1801105 1.00 NPC1 (0.71) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL1799549 0.88 CYP3A4 (0.54) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL1795620 0.88 CYP3A4 (0.60) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL8258186 0.86 NPC1 (0.96) NPC1RAB9ACASP3SENP8SENP7
3,5-Diphenylisoxazole SCHEMBL1421260 0.84 NPC1 (1.00) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL4325945 0.84 CYP3A4 (0.66) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL4322416 0.81 CYP3A4 (0.54) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL1229797 0.80 CYP3A4 (0.53) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL28662125 0.80 NPC1 (0.81) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL3896257 0.79 MAPT (0.49) NPC1RAB9ACASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951827-B2 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2011-05-31 US disclosed
CN-1869027-A Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles UNIV NORTH CAROLINA (US) 2006-11-29 CN disclosed
US-20060264487-A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles TIDWELL RICHARD R 2006-11-23 US disclosed
EP-1719767-A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles The University of North Carolina at Chapel Hill (US) 2006-11-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264487-A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles PFAS, DHPS, DDO NPC1 3545/4885RAB9A 1451/4885CASP3 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.